Enviva Inc.
EVA News Today: Stay Updated with the Latest Enviva Inc. News in Real Time
Find EVA news now at Meyka AI. Stay informed with the latest Enviva Inc. stocks updates, including price news, market analysis, and expert insights.
MTZ MasTec Earnings Beat: Q1 2026 Results Exceed Expectations
MasTec (MTZ) Q1 2026 earnings beat estimates with $1.39 EPS and $3.83B revenue. Stock up 5.9% on strong infrastructure demand.
BDRBF Maintained: Analysts Raise Price Targets May 2026
Multiple analysts maintain ratings on Bombardier while raising price targets. Desjardins, RBC, CIBC, and BMO increase targets on May 1, 2026.
RSMDF ResMed Inc. Earnings Beat: Q1 2026 Results
ResMed Inc. (RSMDF) beat EPS estimates by 2.22% and revenue by 0.76% in Q1 2026 earnings report released April 30.
4564.T Stock Down 4.2% in Pre-Market: OncoTherapy Science Analysis
4564.T drops 4.2% in pre-market trading. OncoTherapy Science stock analysis with volume surge and technical signals.
MLM Earnings Beat: Martin Marietta Q1 2026 Results
Martin Marietta Materials beat EPS estimates by 8.43% and revenue by 3.74% in Q1 2026 earnings.
ALNY Earnings Beat: Alnylam Crushes Q1 2026 Estimates
Alnylam Pharmaceuticals (ALNY) crushed Q1 2026 earnings with EPS of $1.51 vs $0.90 estimate, up 68.72%. Revenue hit $1.17B, beating by 4.63%.
AIG Earnings Beat: American International Group Q1 2026 Results
AIG beat EPS estimates with $2.11 vs $1.89 expected, but missed revenue at $7.02B. Stock up 5.3% on earnings.
NPIFF Hold Rating Maintained by Desjardins, May 2026
Desjardins maintains Hold rating on NPIFF, raises price target to C$24 from C$23 on May 1, 2026.
CAH Earnings Beat: Cardinal Health Crushes EPS Estimate
Cardinal Health (CAH) beat EPS estimate by 13.62% with $3.17 actual vs $2.79 expected, but revenue missed slightly at $60.94B.